Content

Inhibition of MDM2 via Nutlin-3 – the next therapy for leural mesothelioma with poor prognosis?

Robert Fred Henry Walter, Fabian Dominik Mairinger, Saskia Ting, Claudia Vollbrecht, Thomas Hager, Karl Worm, Wilfried Eberhardt, Jens Kollemier, Thomas Mairinger, Daniel Christian Christoph, Kurt Werner Schmid, Lutz Freitag, Jeremias Wohlschläger: Inhibition of MDM2 via Nutlin-3 – the next therapy for leural mesothelioma with poor prognosis?. Jahrestagung der deutschen Gesellschaft für Pathologie e. V., Berlin (GER); 06/2014